Skip to content

Clinical trials

Completed Phase 1 Autoimmune Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Phase: Phase 1 Status: Completed Clear all

69 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20034
20041
20061
20073
20093
20102
20112
20132
20145
20151
20163
20176
20184
20193
20204
20215
20226
20233
20245
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed69

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline7
National Institute of Allergy and Infectious Diseases (NIAID)5
Bristol-Myers Squibb2
Kadmon Corporation, LLC2
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany2
National Eye Institute (NEI)2
UCB BIOSCIENCES, Inc.2
UCB Pharma2
Almirall, S.A.1
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases69
Immune System Diseases12
Lupus Erythematosus, Systemic8
Arthritis, Rheumatoid6
Connective Tissue Diseases6
Diabetes Mellitus, Type 15
Multiple Sclerosis5
Crohn Disease4
Diabetes Mellitus4
Arthritis3

Trials

Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.